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This multicentre study examined the inﬂuence of patient demographic, disease status and psychological variables on clinical
geneticists/genetic counsellors (consultants) behaviours in initial consultations with women from high-risk breast cancer families.
One hundred and ﬁfty-eight women completed a pre-clinic self-report questionnaire. The consultations were audiotaped,
transcribed verbatim and coded. Consultants did not vary their behaviour according to women’s expectations. However,
signiﬁcantly more aspects of genetic testing were discussed with women who were affected with breast cancer (P50.001),
screening and management with unaffected women (P=0.01) and breast cancer prevention with younger women (P=0.01).
Prophylactic mastectomy was discussed more frequently with women with medical and allied health training (P=0.02), and
prophylactic oophorectomy with women affected with breast cancer (P=0.03), those in non-professional occupations (P=0.04)
and with a family history of breast and ovarian cancer (P50.001). Consultants used signiﬁcantly more behaviours to facilitate
understanding with women who were in non-professional occupations (P=0.04); facilitated active patient involvement more
with women affected with breast cancer (P50.001) and used more supportive and counselling behaviours with affected
women (P=0.02). This study showed that patient demographics were more likely to predict consultants’ communication
behaviours than the woman’s psychological status. Methods to facilitate assessment of psychological morbidity are needed to
allow more tailored communication.
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Previous research has documented consultants’ reports of the
cancer genetic services typically provided to women from high-risk
breast cancer families. These include cancer risk assessment and
education, facilitation of genetic testing, pre- and post-test counsel-
ling, provision of personally tailored cancer risk management
recommendations, and psychosocial counselling and support
services (NH and MRC, 1999).
A recent survey of Australian clinical geneticists and genetic
counsellors identiﬁed the provision of individualised care as the
single most important goal of genetic counselling (Lobb et al,
2001). These consultants emphasised the variability in women’s
current levels of expectations and needs when they attend genetic
counselling and the importance of tailoring communication
accordingly.
Studies that have examined levels of breast cancer genetics
knowledge among women with a family history of breast cancer
(Lerman et al, 1996, 1997; Hughes et al, 1997; Wonderlick and
Fine, 1997; Cull et al, 1998; Bluman et al, 1999; Donovan and
Tucker, 2000) have found wide variation in knowledge about many
facets of genetic testing, including the cancer risks associated with
different genes and different mutations and the effectiveness of
interventions, for example screening, chemoprevention, or surgery
for reducing risk (Geller et al, 1997; Audrain et al, 1998; Bluman et
al, 1999).
Similarly, there is wide variation in the accuracy of women’s
perceptions of their likelihood of developing breast cancer. For
example, the percentage of women who overestimated their risk
after counselling has ranged from 14% to 89% (Evans et al,
1994; Lerman et al, 1995; Lloyd et al, 1996; Watson et al, 1999).
Such over-estimation is associated with high levels of anxiety,
and unless corrected, may lead to poorly informed decisions
regarding breast cancer screening (Lerman et al, 1993; Alexander
et al, 1996; Kash, 1996). Thus it is important to identify strategies
which will optimise understanding and psychological adjustment,
and these strategies are likely to vary according to the presenting
characteristics of the women.
However, it is not known whether consultants tailor the consul-
tation to the individual woman. No previous study has
documented what actually happens in genetic counselling consulta-
tions with women from high-risk breast cancer families. This study
assessed the process of genetic counselling for Australian women
from familial breast cancer families and examined whether differing
patient demographics, disease status (unaffected/affected) or
psychological variables inﬂuence consultant communication.
C
l
i
n
i
c
a
l
Received 18 December 2001; revised 23 April 2002; accepted 6 June 2002
*Correspondence: EA Lobb; E-mail: lizlobb@med.usyd.edu.au
British Journal of Cancer (2002) 87, 502–508
ã 2002 Cancer Research UK All rights reserved 0007–0920/02 $25.00
www.bjcancer.comMETHODS AND MATERIALS
Participants
Women assessed to be at potentially high risk for the development
of breast cancer because of their family history, and who were
attending their ﬁrst consultation in any one of 10 familial cancer
clinics in four Australian States (New South Wales, Victoria, South
Australia and Queensland), were included in the study. Women
were quota-sampled according to whether or not they had
previously had breast cancer. Women were considered ineligible
for participation if they were unable to give informed consent, that
is, if they were younger than 18 years or showed evidence of a
severe mental illness. Individuals with limited literacy in English
were also excluded because data collection was based on self-admi-
nistered questionnaire.
A sample size of 158 women is sufﬁcient to detect an association
between patient characteristics and consultants’ behaviours of a
magnitude of 0.3, that is a small to medium effect size, at a 0.05
level of signiﬁcance with a power of 80%.
Procedure
This study is one component of a larger randomised controlled
trial of providing women with an audiotape of their genetic coun-
selling consultation, the results of which will be reported separately.
Staff at each of the participating clinics invited women to partici-
pate in the study when they telephoned to make their
appointment. If verbal agreement was obtained, women were
mailed a self-administered questionnaire prior to their genetic
consultation that they returned in a pre-paid envelope. The consul-
tations were audiotaped and copies of the audiotape were retained
for analysis. Ethics approval from 10 different ethics committees
responsible for each of the participating clinics was sought and
obtained prior to data collection.
Measures
Demographic characteristics Women were asked to provide
details on age, education, occupation, marital status, language
spoken at home, parents’ country of birth, marital status, medi-
cal or allied health training, religious afﬁliation or spiritual belief
and the number of biological children and sex and age of each
child.
Cancer burden Number of ﬁrst- and second-degree relatives
who had developed and/or died of breast or ovarian cancer were
collected from study participants as a measure of ‘cancer burden’.
Breast cancer knowledge An eight-item true–false measure
assessed knowledge about breast cancer genetics. The scale is a
revised version of a measure previously used in a study on the
psychological impact of BRCA1 testing (Lerman et al, 1996). The
scale has been found in previous studies to have moderate internal
consistency with Cronbach’s co-efﬁcient alpha of 0.59 (Meiser et al,
2001).
Expectations Women were asked to indicate on a ﬁve-point
scale ranging from ‘not at all important’ to ‘very important’ their
response to seven possible reasons for attending a genetic clinic
and to similarly rate nine possible information topics they might
want covered at their ﬁrst appointment. This scale was developed
for the purposes of this study and included items suggested by
expert opinion, the literature and structured telephone interviews
with at risk women. Whether expectations were met was deter-
mined by comparing for each woman what she expected and
what she got according to the coded transcribed consultation.
Risk perception Women were asked to indicate their perceived
approximate lifetime risk (i.e. to age 80) of breast cancer (or, if
affected, a second breast cancer) by choosing between seven
response options ranging from 1–100%. A decision was made to
code women’s risk accuracy within categories, as risk estimates vary
widely and often only a general risk category (e.g. high, medium or
low) is given in the genetic counselling session. Participants’
numerical estimate of life time risk was converted to a category
according to the ﬁgures given in the Australian National Health
and Medical Research Council Guidelines e.g. a potentially high
risk category 25–80%; a medium risk category 12–25% and a
low risk category 9–12% (NH and MRC, 1999).
Objective risk This was determined by the ﬁgure given by the
consultants in the consultation or the post consultation summary
letter (all women received a ﬁgure in either of these communica-
tions). Participants’ responses were deemed accurate if their risk
estimate ﬁtted within the risk category given by the consultant. If
women were inaccurate it was determined whether they had
under-estimated or over-estimated their risk of breast cancer.
Breast cancer-speciﬁc anxiety This was measured using the
Impact of Events Scale, a 15-item validated scale measuring intru-
sion and avoidance responses in relation to a speciﬁc stressor
(Horowitz et al, 1979). In the current study the particular stressor
was concern about being at risk of developing breast cancer for
unaffected women and concern about developing a second cancer
for affected women. In a previous validation study of women with
a family history of breast cancer, the intrusion and the avoidance
sub-scales have been found to be highly consistent with Cronbach’s
coefﬁcient alpha of 0.84 and 0.91 respectively, and a test-retest
reliability of r=0.80 (Thewes et al, 2001). Scores above 40 on either
scale indicate a signiﬁcant stress response.
General anxiety and depression The 14-item Hospital Anxiety
and Depression Scale has been found to be valid and reliable in
detecting depression and anxiety in hospital medical outpatient
clinics. It consists of two sub-scales of seven items assessing the
level of anxiety and depression (Zigmond and Snaith, 1983). Scores
range from 0–42. Questions have four response options, yielding
scores ranging from 0–21 for each sub-scale. A score of higher
than 10 on either sub-scale is an indication of clinical anxiety or
depression, and scores from 8–10 on either sub-scale are indicative
of ‘borderline’ anxiety and depression.
Coding of transcripts of audio-tapes
A detailed coding system and coding manual for the transcribed
audiotapes was devised. The coder’s manual was developed to
enable standardisation of the coding procedure and to facilitate
calculation of inter-rater reliability.
The transcripts were coded to capture 10 aspects of the genetic
counselling that encompassed (a) Information giving behaviours: (i)
breast cancer genetics; (ii) genetic testing; (iii) family history and
risk; (iv) prophylactic surgery; (v) breast cancer prevention; (vi)
screening and management; and (b) Process behaviours: (vii) facil-
itating patient involvement; (viii) understanding; (ix) patient
centredness and partnership building; and (x) supportive and
counselling behaviours. These categories were based on (i) the
National Health and Medical Research Council’s Guidelines on
the Familial Aspects of Cancer: A Guide to Clinical Practice (NH
and MRC, 1999), (ii) an Australian survey of clinical geneticists/
genetic counsellors describing their practice (Lobb et al, 2001)
and (iii) studies that identiﬁed women’s expectations of the genetic
counselling session (Hopwood et al, 1993; Julian-Reynier et al,
1996, 1998; Hallowell et al, 1997; Michie et al, 1997; Veach et al,
1999; Brain et al, 2000).
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(5), 502–508Under each of these categories the content or behaviours that
characterised that issue were identiﬁed. The presence or absence
of each component was coded. Whether the woman or the genetic
counsellor/geneticist initiated the content was noted and ﬁnally, the
actual words used were recorded. An example of coding for an
information giving behaviour is shown in Table 1 and a process
variable is shown in Table 2. For example the category of Genetic
Testing has eight component behaviours that were summed to
provide a total score.
Coding reliability
Three coders (including EL) were trained. Two coders re-coded a
random 10% of their own consultation transcripts and 10% of
the other coder’s consultation transcripts to determine intra-and
inter-rater reliability. There were 274 content coding variables for
each consultation. The average inter-rater reliability over the 274
codes was 93% (range 67–100%) and the average intra-rater relia-
bility was 92% (range 65–100%). The areas of highest agreement
were information-giving categories: risk (96–100%); screening
(89–99%); genetic testing (84–99%); prevention (91–100%);
and there were lower levels of agreement on some consultant
communication facilitation behaviours: facilitating communication
(67–87%) and discussing psycho-social issues (69–76%). Thus
interpretation of ﬁndings on these latter variables must be made
with some caution.
Statistical methods
Descriptive statistics (frequencies, means and medians) were used
to summarise most of the data, including demographics and
psychological status. Frequencies were calculated for each consul-
tant behaviour. Total scores for the 10 pre-deﬁned counselling
categories were calculated by summing the component behaviours.
Univariate analyses exploring associations between the demo-
graphic, expectation, psychological, knowledge and family history
predictors listed above and total scores for each counselling cate-
gory were undertaken using parametric statistics (t-tests and
Pearson’s correlations) if the category total score was normally
distributed and non-parametric statistics (Mann–Whitney U and
Spearman’s correlations) if the category total score was non-
normally distributed. Some individual consultation behaviours
are analysed by chi square analyses. Variables associated with the
outcomes at P50.25 (Hosmer and Lemeshoe, 1989) were included
in multivariate analyses (linear regression if normally distributed,
logistic regression with the dependent variable re-categorised above
and below the median if non-normally distributed).
RESULTS
Of the 231 women who met eligibility criteria, 11 women declined
participation and 27 women did not attend their appointment. Of
the remaining 193 women, 158 women completed baseline (and
follow-up) questionnaires, for whom there was an audible audio-
tape of their consultation for verbatim transcription.
Of the ﬁnal sample (n=158), 89 women were unaffected with
breast cancer (56%) and 69 were affected (44%). The majority
had a family history of breast cancer (77%) and almost a quarter
had a family history of breast and ovarian cancer (23%). The
median age of participants was 42 (range 19–79) s.d.=11.9. The
majority of women were married or in a de facto relationship
(76%). Over half the women were educated above year 12
(55%) and 57% were in professional or semi-professional occupa-
tions while 33% had some form of medical or allied health
training.
Genetic counselling consultations were given by ﬁve clinical
geneticists and two genetic counsellors. Three of the geneticists
were male, two female, and all genetic counsellors were female.
They were all very experienced in providing services to women
from high risk families, and worked within a familial cancer
clinic.
Baseline characteristics
Women’s knowledge of breast cancer genetics Prior to the
clinic visit, women gave a mean of ﬁve correct answers on the eight
breast cancer genetics knowledge scale. Areas where fewer women
gave correct answers concerned the role of male inheritance, the
presence of more than one breast cancer pre-disposition gene
and the effectiveness of bilateral mastectomy in reducing breast
cancer risk. Multivariate analysis showed that women younger than
42 years (OR=0.469, 95%CI=0.247–0.889, P=0.02) and women in
professional occupations (OR=0.490, 95%CI=0.262–0.917,
P=0.03) gave more correct answers.
Women’s risk perception at baseline Just under half of unaf-
fected women estimated their risk of breast cancer accurately. Of
the women who were inaccurate, half underestimated and half over-
estimated their risk. Accuracy of risk perception prior to counselling
was signiﬁcantly associated with a higher educational level with 67%
of women educated above year 12 being accurate compared to 33%
of women educated below year 12 (w
2
1=5.15, P=0.02).
Psychological Status The majority of unaffected and affected
women had normal scores on the Impact of Events Scale (intru-
sion and avoidance responses) prior to counselling. A small sub
group of unaffected (10%) and affected (19%) women showed
signiﬁcant stress responses. Almost one-ﬁfth of unaffected and
affected women were clinically anxious and 18% of unaffected
women and 28% of affected women were ‘borderline’ clinically
anxious. Five per cent (5%) of both unaffected and affected
women were clinically depressed and 8% of unaffected and
16% of affected women were ‘borderline’ clinically depressed.
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Table 1 Information giving behaviours
Content of behaviour % of consultations occurred
Genetic testing
Beneﬁts of testing 46
How testing is done 83
Impact on insurance 42
Delay in results 74
Uncertainty of test 58
Who to tell 24
Patient’s preference not to know results 46
Impact of results on family members 57
Table 2 Process variables
% of consultations
Content of behaviour occurred
Facilitating patient understanding and involvement
Checking patient’s knowledge of medical terminology 61
Explaining medical terms 26
Checking patient’s understanding 58
Clarifying misunderstanding 11
Summarising 48
Inviting questions 71
Offering supplementary information 39
Discussing referral to consultation 69
Using an analogy 70
Using diagrams 52
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British Journal of Cancer (2002) 87(5), 502–508 ã 2002 Cancer Research UKThese results are not dissimilar to others reported for affected
and unaffected women (Maguire et al, 1980; Meiser et al,
2000). Compared to the normal population, levels of psychologi-
cal morbidity were not notably high for unaffected women, but
anxiety was certainly higher in affected women and if probable
cases are included, rates of clinically signiﬁcant depression were
also higher.
Women’s expectations of the genetic counselling session The
vast majority of women came to genetic counselling to obtain
information about prevention, surveillance and risk information
for themselves and for their children. A large percentage (82%)
expected a genetic test, while just under half the sample expected
to discuss prophylactic surgery. About half the women expected
to discuss their feelings and receive reassurance.
Table 3 represents a comparison between what women expected
to receive from their genetic counselling session (as reported in
their baseline questionnaire) and what they received (measured
by examining the transcripts of their session). In two-thirds of
consultations, the woman was asked her reason for attending
genetic counselling (her agenda), offering the consultant an oppor-
tunity to assess expectations. Women’s expectations to receive
information about risk and aspects of preventative surgery were
generally met. However, many women who did not expect this
information also received it, as these topics appeared to be stan-
dard components of the genetic counselling consultation.
Univariate statistical testing showed no relationship between base-
line expectations concerning these topics and consultant behaviour.
Similarly, there were no relationships between baseline expectations
for discussion of feelings and reassurance, or for a genetic test, and
consultant behaviours.
About half of the women who wanted information about
hormone replacement therapy (HRT) and the oral contraceptive
pill (OCP) received it, while about a third of the group who
did not expect these topics to be covered nevertheless discussed
them. Univariate tests revealed a signiﬁcant relationship between
expectations and consultation behaviour concerning OCP
(w
2
1=6.3, P50.01). Very few women expected or received infor-
mation about IVF. A larger number (38) expected to discuss
the impact of breast cancer risk on child bearing decisions, and
those with this expectation were more likely to discuss it
(w
2
1=5.1, P=0.05).
Did consultants tailor their consultations according to
demographic and psychological characteristics?
A summary of the signiﬁcant ﬁndings of predictors of consultants’
communication behaviours is shown in Table 4. Multivariate
analyses showed that consultants used signiﬁcantly more beha-
viours that facilitated understanding with women who were in
non-professional occupations (mean 5.5) than professional women
(mean 4.8) (t=2.088, P=0.04), with a trend towards using more
behaviours if the woman was anxious (median 5.3 compared to
4.9), (t=1.739, P=0.08). They used more behaviours to facilitate
active patient involvement with women who were affected with
breast cancer (median 3.0) compared to unaffected women
(median 2.0), (OR=2.748, 95%CI=1.705–7.942, P=0.000).
Women’s breast cancer status was found to be a signiﬁcant
predictor of supportive behaviours with consultants using more
such behaviours with affected women (mean 4.0) than unaffected
women (mean 3.1), (t123=72.375, P=0.02).
No signiﬁcant predictors were found of discussing family history
and breast cancer genetics, which occurred in most consultations,
nor of partnership building behaviours.
More aspects of genetic testing were discussed with affected
women (median 5) than with unaffected women (median 4)
(OR=3.593, 95%CI=1.786–7.225, P=0.000), while the reverse was
true for information on screening and management (median of
4.2 issues discussed with unaffected women versus 3.2 with affected
women) (t=72.678, P=0.01). Non-medical strategies to prevent
breast cancer (such as diet) were discussed more frequently with
younger women aged 42 years or less, (median 2.0 behaviours)
compared to older women (median 1.5) (P=0.01).
Prophylactic surgery was discussed in half of the consultations, but
its discussion was initiated by the consultant in only a third of these
consultations. Multivariate analyses showed that prophylactic
mastectomy was more likely to be discussed with women who had
some form of medical training (OR=6.872, 95%CI=1.290–36.597,
P=0.02),andlesswithwomenwhounderestimatedtheirbreastcancer
risk (OR=0.256, 95%CI=0.054–1.216, P=0.09). Prophylactic
oophorectomy was discussed more with women who were affected
with breast cancer (OR=2.126, 95%CI=1.054–4.289, P=0.03),
worked in non-professional occupations (OR=0.470, 95%CI=
0.231–0.953, P=0.04), and who had a family history of breast and
ovarian cancer (OR=4.568, 95%CI=2.017–10.345, P=0.000).
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Table 3 Women’s expectations of the genetic counselling session and whether these expectations were met according to the transcribed audio-tape of
their consultation
a (n=158)
No. of No. and % of women No. of No. and % of women
women who had expectation women who who did not have expectation
who had and got it met according did not have but got it according to
Expectation of consult expectation to the transcribed consult (%) expectation the transcribed consult (%)
A referral for screening 71 5 (7) 81 1 (1.2)
To discuss feelings 86 54 (63) 67 42 (62)
To get reassurance 90 52 (58) 62 35 (56)
To know why family is at risk 145 144 (97) 8 8 (100)
To know about genetic test 131 57 (43) 20 10 (50)
To know breast cancer risk 134 124 (93) 20 10 (50)
To know risk of other cancers 137 98 (71) 20
Information on OCP 45 24 (53) 104 32 (31)
Information on HRT 82 41 (50) 65 25 (38)
Information on IVF 19 3 (16) 130 1 (0.8)
How to manage breast cancer risk (screening and management) 140 113 (81) 14 8 (57)
Advice on preventative surgery 72 54 (75) 76 43 (57)
Inﬂuence of breast cancer risk on child bearing decisions 38 9 (24) 111 10 (9)
What to do about family risk 151 131 (87) 4 1 (25)
aNumbers with and without expectations do not add up to 158 due to missing data.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(5), 502–508Levels of general anxiety and depression, cancer speciﬁc anxiety,
knowledge and risk accuracy were not found to be associated with
any consultant behaviour.
DISCUSSION
This study is the ﬁrst of its kind, and undertook a detailed analysis
of transcripts of genetic counselling sessions with women from
high-risk breast cancer families to identify the process and content
of the consultation. In this paper, predictors of consultant beha-
viour were explored.
Were women’s expectations of genetic counselling met?
Previous authors have argued that the success of the genetic coun-
selling session is dependent upon the counsellor accurately gauging
the woman’s needs and expectations. To avoid a mismatch in the
consultant’s and the woman’s expectations, it has been recom-
mended that the woman’s agenda is discussed at the beginning
of the counselling session (Michie et al, 1998). In this sample,
the consultant elicited the woman’s agenda in the majority of
consultations (69%). However, a third of women were not given
the opportunity to outline their informational and emotional
needs. The impact of eliciting the woman’s agenda and other
consultant behaviours on patient outcomes is not the focus of this
paper, but will be explored in another article.
The ﬁnding that the vast majority of women come to genetic
counselling to obtain information about prevention, surveillance
and risk information for themselves and for their children is simi-
lar to that reported by other studies (Julian-Reynier et al, 1996,
1998; Hallowell et al, 1997;). Four out of ﬁve women expected a
genetic test, over a third expected a physical examination (33%)
and just under half expected a referral for screening (43%).
Where the woman’s agenda matched the consultant’s (for infor-
mation about breast cancer genetics and risk) most women
received what they expected. However, women who were not
expecting these facts were also likely to receive them, suggesting
that consultants gave this information in a standard, rather than
tailored manner. For example, half of women who had not
expected to discuss their breast cancer risk did so.
Where expectations were not well matched (for example, for a
genetic test, a screening referral and reassurance) the majority of
women did not receive what they expected, and their expectations
did not inﬂuence consultants’ behaviour. However, women did
appear more successful in communicating their expectations of
fertility topics, with consultants appearing more responsive to their
expectations. If women’s expectations are unrealistic (for example,
women can only receive a test if they have a living affected rela-
tive), it may be beneﬁcial to discuss this when they make their
genetic counselling appointment, to avoid unrealistic expectations.
The impact of meeting women’s expectations on their satisfaction
with the encounter will be explored in another paper.
Do consultants tailor the consultation according to
demographic and psychological factors?
This study found that breast cancer status was a signiﬁcant predic-
tor of consultants’ behaviours. For example, consultants used
signiﬁcantly more supportive and counselling behaviours with
women who were affected with breast cancer and facilitated more
active patient involvement with such women. Women with breast
cancer are faced with an uncertain prognosis and many experience
clinically signiﬁcant levels of depression and anxiety (Fallowﬁeld et
al, 1990; Kissane et al, 1998). It is likely that consultants were
responding appropriately to these high emotional distress levels
in providing more support.
Affected women in this sample were signiﬁcantly more likely to
be psychologically distressed before the consultation than were
unaffected women. However, levels of anxiety and depression prior
to counselling were not independently associated with consultant
behaviour, suggesting that consultants were depending more on
their knowledge of breast cancer status, than on the individual’s
current state. The literature suggests that under-detection of patient
distress is common in medical practice. For example Ford et al
(1994) found that ﬁve oncologists’ ability to accurately detect
distress in 117 newly referred out-patients was low, with underes-
timation of distress most common. Speciﬁc strategies to explore
emotionality may be required if consultants are to tailor their
behaviour accordingly.
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Table 4 Summary of signiﬁcant results of predictors of consultant’s
behaviour
Mean/median no.
Behaviour of behaviours P value
Facilitating understanding
Anxiety
Above median median 5.3 0.08
Below median median 4.9
Occupation
Professional mean 4.8
Non professional mean 5.5 0.04
Facilitating active involvement
Breast cancer status
Unaffected median 2.0
Affected median 3.0 0.001
Partnership building
No signiﬁcant ﬁndings
Supportive or counselling behaviours
Breast cancer status
Unaffected mean 3.1
Affected mean 4.0 0.001
Discuss family history and family risk
No signiﬁcant ﬁndings
Information on breast cancer genetics
No signiﬁcant ﬁndings
Information on genetic testing
Breast cancer status
Unaffected median 4.0
Affected median 5.0 0.001
Information on screening and management
Breast status
Unaffected median 4.2 0.001
Affected median 3.2
Discussing breast cancer prevention
Age
Mean age 42 or less 2.0 0.01
Mean age 43 or more 1.5
Discussing prophylactic mastectomy %
Medical/allied health training
No 48
Yes 63 0.02
Risk estimation
Underestimate 40 0.09
Overestimate 60
Discussing prophylactic oophorectomy
Family history
Breast cancer alone 32
Breast/ovarian cancer 68 0.001
Occupation
Non-professional 32
Professional 48 0.04
Breast cancer status
Unaffected 37
Affected 47 0.03
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British Journal of Cancer (2002) 87(5), 502–508 ã 2002 Cancer Research UKDoctor behaviours associated with greater patient disclosure of
emotion have been identiﬁed in a number of studies. These
include: open directive questions, focussing on and clarifying
psychological issues, empathic statements, immediate response to
patient cues, summarising, and making educated guesses about
what the patient might be feeling (Goldberg et al, 1993; Maguire
et al, 1996). Improving this aspect of consultants’ behaviour may
be important as it has been shown to have an impact on patient
outcomes in medical consultations (Bertakis et al, 1991). Whether
it is appropriate to raise complex emotional issues within the
limited timeframe of a genetic consultation, and the level of inter-
vention required, remain to be determined.
Similarly, consultants used signiﬁcantly more behaviours that
facilitated understanding (for example summarising, inviting ques-
tions, or using diagrams) with women who were in non-
professional occupations, and there was a trend for consultants
using more of these behaviours if the woman was anxious. This
suggests they were responding appropriately to women whose
understanding might be expected to be poorer. However, levels
of knowledge and risk accuracy prior to counselling were not
related to the level of detail provided about genetics, risk and
screening, suggesting that these were not easy to assess within
the consultation. As with emotional status, routine assessment of
these features before the consultation, fed back to the consultant,
might provide useful cues to the consultant on the level of detail
required by each person. Several instruments to assess understand-
ing are currently available (for example the measure used in the
current study) that might prove useful for this purpose.
Consultants were also more likely to discuss genetic testing and
prophylactic oophorectomy with affected women, and screening
and management issues with unaffected women. Since mutation
detection in Australia is initiated in affected women and unaffected
relatives are only offered predictive testing once a family-speciﬁc
mutation has been identiﬁed, it is not surprising that genetic test-
ing is more frequently discussed with affected women. Nor is it
surprising that prophylactic oophorectomy is more frequently
discussed with affected women (even if their mutation status is
unknown), since it is very likely that they are carriers of a mutation
that may also increase their risk of ovarian cancer. By contrast, an
unaffected woman with unknown mutation status has a less than
one in two chance of being a carrier and thus her a priori risk
of developing ovarian cancer is considerably lower. On the other
hand, screening and preventive strategies, such as taking tamoxifen,
are more relevant to unaffected women, and appropriately
discussed more frequently with them.
The woman’s occupation (and medical training) were also
signiﬁcant predictors of consultant behaviours, in particular,
discussion of prophylactic surgery. Prophylactic surgery was most
commonly raised by the woman herself, and it may be that those
with medical training were more aware of mastectomy as an
option, and therefore initiated the discussion.
Finally, consultants facilitated more active involvement in
affected women. There may be a perception that affected women
are more experienced in the medical encounter, and more familiar
with decision making, and these women certainly have more deci-
sions to make.
Conclusions
This study has concluded that consultants tailor their information
giving according to clinical factors, such as breast cancer status, but
that many other features, such as women’s expectations, their
psychological state and knowledge, do not inﬂuence consultant
behaviour. It is likely that these features are not easy to assess in
the consultation, and strategies to more directly assess these
features, such as through questionnaire or clinical questioning, will
be required if consultants wish to tailor their consultation accord-
ingly.
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